The role of endogenous opioids in non-suicidal self-injurious behavior: Methodological challenges

Neuroscience and Biobehavioral Reviews

Volumn 48, Issue , 2015, Pages 186-189

  Kirtley, Olivia J ^a   O'Carroll, Ronan E ^b   O'Connor, Rory C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Cannabinoids; Ideation; Methodology; NSSI; Opioids; Self harm; Self injury

Indexed keywords

BETA ENDORPHIN; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; ENDORPHIN; OPIATE PEPTIDE;

AFFECT; ALCOHOLISM; AUTOMUTILATION; BORDERLINE STATE; CEREBROSPINAL FLUID; DEPRESSION; DISTRESS SYNDROME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NEUROIMAGING; PAIN THRESHOLD; POSITRON EMISSION TOMOGRAPHY; REVIEW; SUICIDE ATTEMPT; THINKING; BRAIN; CLINICAL CHEMISTRY; METABOLISM; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SCINTISCANNING;

BORDERLINE PERSONALITY DISORDER; BRAIN; CLINICAL CHEMISTRY TESTS; ENDOCANNABINOIDS; HUMANS; NEUROIMAGING; OPIOID PEPTIDES; PAIN; SELF-INJURIOUS BEHAVIOR; THINKING;

EID: 84919683891     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.11.007     Document Type: Review

References (40)

1. Amorim J.A., Gomes de Barros M.V., Valenca M.M. Post-dural (post-lumbar) puncture headache: risk factors and clinical features. Cephalalgia 2012, 32(12):916-923. 10.1177/0333102412453951.
2. Andover M.S., Gibb B.E. Non-suicidal self-injury, attempted suicide and suicidal intent among psychiatric inpatients. Psychiatry Res. 2010, 178:101-105. 10.1016/j.psychres.2010.03.019.
3. Baker D.G., West S.A., Orth D.N., Hill K.K., Nicholson W.E., Ekhator N.N., et al. Cerebrospinal fluid and plasma β-endorphin in combat veterans with post-traumatic stress disorder. Psychoneuroendocrinology 1997, 22(7):517-529.
4. 11C]-carfentanil and positron emission tomography (PET). Pain 2002, 99(3):589-598.
5. Benedetti F., Thoen W., Blanchard C., Vighetti S., Arduino C. Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems. Pain 2013, 154(3):361-367. 10.1016/j.pain.2012.11.007.
6. Bezov D., Lipton R.B., Ashina S. Post-dural puncture headache: Part I. Diagnosis, epidemiology, etiology, and pathophysiology. Headache 2010, 50(7):1144-1152. (The Journal of Head and Face Pain). 10.1111/j. 1526-4610.2010.01699.x.
7. Birnbach D.J., Kuroda M.M., Sternman D., Thys D.M. Use of atraumatic spinal needles among neurologists in the United States. Headache 2001, 41(4):385-390. (The Journal of Head and Face Pain).
8. Bresin K., Gordon K.H. Endogenous opioids and nonsuicidal self-injury: a mechanism of affect regulation. Neurosci. Biobehav. Rev. 2013, 37(3):374-383. 10.1016/j.neubiorev.2013.01.020.
9. Bruehl S., Burns J.W., Chung O.Y., Chont M. What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function?: Beta-endorphin and opioid function. Eur. J. Pain 2012, 16(3):370-380. 10.1002/j. 1532-2149.2011.00021.x.
10. Button K.S., Ioannidis J.P.A., Mokrysz C., Nosek B.A., Flint J., Robinson E.S.J., Munafò M.R. Power failure: why small sample size undermines the reliability of neuroscience. Nat. Rev. Neurosci. 2013, 14(5):365-376. 10.1038/nrn3475.
11. Coid J., Allolio B., Rees L.H. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet 1983, 322(8349):545-546.
12. Davis A., Dobson R., Kaninia S., Espasandin M., Berg A., Giovannoni G., Schmierer K. Change practice now! Using atraumatic needles to prevent post lumbar puncture headache. Eur. J. Neurol. 2014, 21(2):305-311. 10.1111/ene.12307.
13. De Riu P.L., Petruzzi V., Caria M.A., Mameli O., Casu A.R., Nuvoli S., et al. β-Endorphin and cortisol levels in plasma and CSF following acute experimental spinal traumas. Physiol. Behav. 1997, 62(1):1-5.
14. 11C] carfentanil: reference-tissue methods. Nucl. Med. Biol. 2003, 30(2):177-186.
15. Gratz K.L., Hepworth C., Tull M.T., Paulson A., Clarke S., Remington B., Lejuez C.W. An experimental investigation of emotional willingness and physical pain tolerance in deliberate self-harm: the moderating role of interpersonal distress. Compr. Psychiatry 2011, 52(1):63-74. 10.1016/j.comppsych.2010.04.009.
16. Hawton K., Harriss L., Rodham K. How adolescents who cut themselves differ from those who take overdoses. Eur. Child Adolesc. Psychiatry 2010, 19:513-523. 10.1007/s00787-009-0065-0.
17. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology 1997, 129(2):99-111.
18. Hill M., Miller G., Ho W.-S., Gorzalka B., Hillard C. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 2008, 41(2):48-53. 10.1055/s-2007-993211.
19. 11C] carfentanil: a test-retest study in healthy subjects. Eur. J. Nucl. Med. Mol. Imaging 2009, 36(2):275-286. 10.1007/s00259-008-0935-6.
20. Hirvonen J., Zanotti-Fregonara P., Umhau J.C., George D.T., Rallis-Frutos D., Lyoo C.H., et al. Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography. Mol. Psychiatry 2012, 18(8):916-921. 10.1038/mp.2012.100.
21. Holden J.E., Jeong Y., Forrest J.M. The endogenous opioid system and clinical pain management. AACN Adv. Crit. Care 2005, 16(3):291-301.
22. Hooley J.M., Ho D.T., Slater J., Lockshin A. Pain perception and nonsuicidal self-injury: a laboratory investigation. Personal Disord.: Theory Res. Treat. 2010, 1(3):170-179. 10.1037/a0020106.
23. Howlett A.C., Barth B.F., Bonner T.I., Cabral G., Casellas P., Devane W.A., et al. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54(2):161-202.
24. Lavi R., Yernitzky D., Rowe J.M., Weissman A., Segal D., Avivi I. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology 2006, 67(8):1492-1494. 10.1212/01.wnl.0000240054.40274.8a.
25. McDonald J., Lambert D.G. Opioid receptors. Continuing education in anaesthesia. Crit. Care Pain 2005, 5(1):22-25. 10.1093/bjaceaccp/mki004.
26. Mechoulam R., Parker L.A. The endocannabinoid system and the brain. Ann. Rev. Psychol. 2013, 64(1):21-47. 10.1146/annurev-psych-113011-143739.
27. Nock M.K., Prinstein M.J., Sterba S.K. Revealing the form and function of self-injurious thoughts and behaviors: a real-time ecological assessment study among adolescents and young adults. J. Abnorm. Psychol. 2009, 118(4):816-827. 10.1037/a0016948.
28. O'Connor R.C., Rasmussen S., Miles J., Hawton K. Self-harm in adolescents: self-report survey in schools in Scotland. Br. J. Psychiatry 2009, 194:68-72. 10.1192/bjp.bp.107.047704.
29. O'Connor R.C., Rasmussen S., Hawton K. From thoughts to action: distinguishing adolescents who think about self-harm from those who engage in self-harm. Br. J. Psychiatry 2012, 200:330-335. 10.1192/bjp.bp.111.097808.
30. O'Connor R.C., Rasmussen S., Hawton K. Adolescent self-harm: a school-based study in northern Ireland. J. Affect. Disord. 2014, 159:46-52.
31. Prossin A.R., Love T.M., Koeppe R.A., Zubieta J.-K., Silk K.R. Dysregulation of regional endogenous opioid function in borderline personality disorder. Am. J. Psychiatry 2010, 167(8):925-933.
32. Russ M.J., Roth S.D., Kakuma T., Harrison K., Hull J.W. Pain perception in self-injurious borderline patients: naloxone effects. Biol. Psychiatry 1994, 35(3):207-209.
33. Smith Y.R., Stohler C.S., Nichols T.E., Bueller J.A., Koeppe R.A., Zubieta J.K. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J. Neurosci. 2006, 26(21):5777-5785. 10.1523/JNEUROSCI. 5223-05.2006.
34. Stanley B., Sher L., Wilson S., Ekman R., Huang Y., Mann J.J. Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J. Affect. Disord. 2010, 124(1-2):134-140. 10.1016/j.jad.2009.10.028.
35. Tohmo H., Vuorinen E., Muuronen A. Prolonged impairment in activities of daily living due to postdural puncture headache after diagnostic lumbar puncture. Anaesthesia 1998, 53(3):299-302. 10.1046/j. 1365-2044.1998.00326.x.
36. Tordjman S., Anderson G.M., Botbol M., Brailly-Tabard S., Perez-Diaz F., Graignic R., et al. Pain reactivity and plasma β-endorphin in children and adolescents with autistic disorder. PLoS One 2009, 4(8):e5289. 10.1371/journal.pone.0005289.
37. 11C]carfentanil. NeuroImage 2012, 61(3):670-676. 10.1016/j.neuroimage.2012.03.063.
38. van Hell H.H., Bossong M.G., Jager G., Kahn R.S., Ramsey N.F. Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition: pharmacological imaging of the cannabinoid system (PhICS). Int. J. Methods Psychiatr. Res. 2011, 20(1):10-27. 10.1002/mpr.327.
39. Vincent K., Tracey I. Sex hormones and pain: the evidence from functional imaging. Curr. Pain Headache Rep. 2010, 14(5):396-403. 10.1007/s11916-010-0139-1.
40. Zubieta J.-K., Dannals R.F., Frost J.J. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am. J. Psychiatry 1999, 156(6):842-848.